BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 16803492)

  • 1. High-dose rate brachytherapy in the treatment of carcinoma of uterine cervix: twenty-year experience with cobalt after-loading system.
    Mosalaei A; Mohammadianpanah M; Omidvari S; Ahmadloo N
    Int J Gynecol Cancer; 2006; 16(3):1101-5. PubMed ID: 16803492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose-rate brachytherapy in the treatment of uterine cervix cancer. Analysis of dose effectiveness and late complications.
    Ferrigno R; dos Santos Novaes PE; Pellizzon AC; Maia MA; Fogarolli RC; Gentil AC; Salvajoli JV
    Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1123-35. PubMed ID: 11483321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transperineal low-dose rate iridium-192 interstitial brachytherapy in cervical carcinoma stage IIB.
    Budrukkar AN; Shrivastava SK; Jalali R; Agarwal JP; Deshpande DD; Nehru RM; Dinshaw KA
    Strahlenther Onkol; 2001 Oct; 177(10):517-24. PubMed ID: 11680016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of low and high dose rate brachytherapy in the treatment of uterine cervix cancer. Retrospective analysis of two sequential series.
    Ferrigno R; Nishimoto IN; Novaes PE; Pellizzon AC; Maia MA; Fogarolli RC; Salvajoli JV
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1108-16. PubMed ID: 15990016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose-rate brachytherapy in uterine cervical carcinoma.
    Patel FD; Rai B; Mallick I; Sharma SC
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):125-30. PubMed ID: 15850912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulsed low dose rate brachytherapy for uterine cervix carcinoma.
    Rogers CL; Freel JH; Speiser BL
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(1):95-100. PubMed ID: 9989519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High dose rate cobalt-60 afterloading intracavitary therapy of uterine cervical carcinomas in Srinagarind hospital - analysis of complications.
    Pesee M; Krusun S; Padoongcharoen P
    Asian Pac J Cancer Prev; 2010; 11(2):491-4. PubMed ID: 20843138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations.
    Pötter R; Knocke TH; Fellner C; Baldass M; Reinthaller A; Kucera H
    Cancer Radiother; 2000; 4(2):159-72. PubMed ID: 10812362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II study of the American Brachytherapy Society guidelines for the use of high-dose rate brachytherapy in the treatment of cervical carcinoma: is 45-50.4 Gy radiochemotherapy plus 31.8 Gy in six fractions high-dose rate brachytherapy tolerable?
    Shakespeare TP; Lim KH; Lee KM; Back MF; Mukherjee R; Lu JD;
    Int J Gynecol Cancer; 2006; 16(1):277-82. PubMed ID: 16445645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulsed-dose-rate intracavitary brachytherapy for cervical carcinoma: the AIIMS experience.
    Rath GK; Sharma DN; Julka PK; Subramani V; Bahl A; Haresh KP
    Am J Clin Oncol; 2010 Jun; 33(3):238-41. PubMed ID: 19841576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two fractions of high-dose-rate brachytherapy in the management of cervix cancer: clinical experience with and without chemotherapy.
    Sood BM; Gorla G; Gupta S; Garg M; Deore S; Runowicz CD; Fields AL; Goldberg GL; Anderson PS; Vikram B
    Int J Radiat Oncol Biol Phys; 2002 Jul; 53(3):702-6. PubMed ID: 12062615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carcinoma of the cervix: analysis of complications after primary external beam radiation and Ir-192 HDR brachytherapy.
    Kapp KS; Stuecklschweiger GF; Kapp DS; Poschauko J; Pickel H; Hackl A
    Radiother Oncol; 1997 Feb; 42(2):143-53. PubMed ID: 9106923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose-rate vs. high-dose-rate intracavitary brachytherapy for carcinoma of the cervix: The University of Alabama at Birmingham (UAB) experience.
    Falkenberg E; Kim RY; Meleth S; De Los Santos J; Spencer S
    Brachytherapy; 2006; 5(1):49-55. PubMed ID: 16563997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors in patients with carcinoma of the uterine cervix treated with external beam irradiation and IR-192 high-dose-rate brachytherapy.
    Kapp KS; Stuecklschweiger GF; Kapp DS; Poschauko J; Pickel H; Lahousen M; Hackl A
    Int J Radiat Oncol Biol Phys; 1998 Oct; 42(3):531-40. PubMed ID: 9806511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective multi-institutional study of definitive radiotherapy with high-dose-rate intracavitary brachytherapy in patients with nonbulky (<4-cm) stage I and II uterine cervical cancer (JAROG0401/JROSG04-2).
    Toita T; Kato S; Niibe Y; Ohno T; Kazumoto T; Kodaira T; Kataoka M; Shikama N; Kenjo M; Tokumaru S; Yamauchi C; Suzuki O; Sakurai H; Numasaki H; Teshima T; Oguchi M; Kagami Y; Nakano T; Hiraoka M; Mitsuhashi N
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):e49-56. PubMed ID: 21470794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose-rate remote afterloading irradiation of carcinoma of the cervix in Hong Kong: unexpectedly high complication rate.
    Choi P; Teo P; Foo W; O SK; Leung SF; Tsao SY; Shiu W
    Clin Oncol (R Coll Radiol); 1992 May; 4(3):186-91. PubMed ID: 1586638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective randomized study concerning the point A dose in high-dose rate intracavitary therapy for carcinoma of the uterine cervix. The final results.
    Chatani M; Matayoshi Y; Masaki N; Teshima T; Inoue T
    Strahlenther Onkol; 1994 Nov; 170(11):636-42. PubMed ID: 7974179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extended-field radiotherapy and high-dose-rate brachytherapy in carcinoma of the uterine cervix: clinical experience with and without concomitant chemotherapy.
    Sood BM; Gorla GR; Garg M; Anderson PS; Fields AL; Runowicz CD; Goldberg GL; Vikram B
    Cancer; 2003 Apr; 97(7):1781-8. PubMed ID: 12655536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrasound-assisted endocavitary HDR-Ir(192) brachytherapy for unresectable locally advanced uterine cervix carcinoma: retrospective analysis focusing the efficacy and tolerability.
    Koukourakis GV; Miliadou A; Tsalafoutas I; Gkeli MG; Sotiropoulou-Lontou A
    Clin Transl Oncol; 2013 Feb; 15(2):154-9. PubMed ID: 22855184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiotherapy alone in the treatment of uterine cervix cancer with telecobalt and low-dose-rate brachytherapy: retrospective analysis of results and variables.
    Ferrigno R; Campos de Oliveira Faria SL; Weltman E; Salvajoli JV; Segreto RA; Pastore A; Nadalin W
    Int J Radiat Oncol Biol Phys; 2003 Mar; 55(3):695-706. PubMed ID: 12573757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.